Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Building wealth without taking high risks is achievable with the right strategies. Explore options that prioritize safety and growth.
27,007 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Intuitive Surgical dominates robotic-assisted surgery, and its moat is getting stronger. This piece breaks down why t...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...
A disciplined look at AMEX shares through the lens of value, growth, and risk. Learn how to judge whether american ex...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...
A rare mix of weak jobs data rising and rising oil prices is reshaping market readings. This guide explains what it m...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
Oil markets swing, but some investors seek steady income through pipeline stocks paying a 7.3% dividend. This guide e...
The iShares Semiconductor ETF surged in the first half of 2026, powered by AI infrastructure demand and a rebound in ...
Amazon isn’t only about Prime or AWS. An underrated reason to invest Amazon stock is its fast-growing advertising bus...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...